9th INT'L BIO FORUM & BIO EXPO JAPAN from June 30 - July 2, 2010

9th INT'L BIO FORUM & BIO EXPO JAPAN, organised by Reed Exhibitions Japan, will come back again as Asia's largest bio-event from June 30 - July 2, 2010. One of the hottest feature topics is "antibody drugs".

One of the major reasons is the changing market, where new medicines are required because of "2010 problem", along with the aging society, where types of disorder are shifting into cancer from adult diseases. Under such circumstances, what kind of developments and challenges does antibody drug face? What kind of symptoms are on the table? Full information will be revealed in INT'L BIO FORUM & BIO EXPO JAPAN.

Special Session

250 sessions cover the hottest topics in biotechnology business development, research, marketing trends, best practice and more, with globally-recognised speakers.

Bio Academic Forum

Researchers and scientists deliver presentations on their latest researches on biotechnology, where you have opportunities to have meetings face to face with them on-site.

Exhibition

650 exhibitors will be participating, where latest technologies and products will be lined up, with opportunities for technical consultations available at the show venue.

Source INT'L BIO FORUM & BIO EXPO JAPAN

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes drugs linked to higher risk of rare optic nerve damage